BeiGene Research Development from 2010 to 2026
| ONC Stock | 359.05 4.19 1.18% |
Research Development | First Reported 2014-03-31 | Previous Quarter 524.9 M | Current Value 523.7 M | Quarterly Volatility 188.1 M |
Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 207.4 M, Interest Expense of 63.4 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 0.67, Dividend Yield of 0.0 or PTB Ratio of 0.61. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
BeiGene | Research Development | Build AI portfolio with BeiGene Stock |
Analyzing BeiGene's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing BeiGene's current valuation and future prospects.
Latest BeiGene's Research Development Growth Pattern
Below is the plot of the Research Development of BeiGene over the last few years. It is BeiGene's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
BeiGene Research Development Regression Statistics
| Arithmetic Mean | 872,868,468 | |
| Geometric Mean | 244,413,111 | |
| Coefficient Of Variation | 101.42 | |
| Mean Deviation | 785,387,790 | |
| Median | 679,005,000 | |
| Standard Deviation | 885,304,602 | |
| Sample Variance | 783764.2T | |
| Range | 2.3B | |
| R-Value | 0.96 | |
| Mean Square Error | 67401.1T | |
| R-Squared | 0.92 | |
| Slope | 168,100,773 | |
| Total Sum of Squares | 12540227.8T |
BeiGene Research Development History
About BeiGene Financial Statements
BeiGene stakeholders use historical fundamental indicators, such as BeiGene's Research Development, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 2.2 B | 2.4 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:Check out the analysis of BeiGene Correlation against competitors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Biotechnology sector continue expanding? Could BeiGene diversify its offerings? Factors like these will boost the valuation of BeiGene. Anticipated expansion of BeiGene directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BeiGene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.5 | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
Understanding BeiGene requires distinguishing between market price and book value, where the latter reflects BeiGene's accounting equity. The concept of intrinsic value - what BeiGene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push BeiGene's price substantially above or below its fundamental value.
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, BeiGene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.